Guardian Pharmacy Services (GRDN) Liabilities and Shareholders Equity (2023 - 2026)

Guardian Pharmacy Services has disclosed Liabilities and Shareholders Equity across 4 years of filings, most recently posting $426.9 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $426.9 million, up 27.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 58.15% YoY), and the FY2025 annual result was $412.7 million, up 28.63% from the prior year.
• Liabilities and Shareholders Equity came in at $426.9 million for Q1 2026 at Guardian Pharmacy Services, up from $412.7 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $426.9 million in Q1 2026 to a low of $271.2 million in Q4 2023.
• The 4-year median for Liabilities and Shareholders Equity is $352.2 million (2024), against an average of $357.5 million.
• Peak annual rise in Liabilities and Shareholders Equity reached 28.63% in 2025, while the deepest fall reached 12.07% in 2025.
• Guardian Pharmacy Services' Liabilities and Shareholders Equity stood at $271.2 million in 2023, then grew by 18.31% to $320.8 million in 2024, then gained by 28.63% to $412.7 million in 2025, then grew by 3.46% to $426.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $426.9 million (Q1 2026), $412.7 million (Q4 2025), and $390.0 million (Q3 2025), per Business Quant data.